These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 34967557)
1. Uncovering Philip Morris International's Fundamental Strategies for Product Placement in Thailand: Spotlighting Industry Penetration to Advance the Endgame. Charoenca N; Kungskulniti N; Hamann S; Mock J Asian Pac J Cancer Prev; 2021 Dec; 22(12):3789-3801. PubMed ID: 34967557 [TBL] [Abstract][Full Text] [Related]
2. How to combat efforts to overturn bans on electronic nicotine delivery systems: lessons from tobacco industry efforts during the 1980s to open closed cigarette markets in Thailand. Patanavanich R; Glantz SA BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33500264 [TBL] [Abstract][Full Text] [Related]
3. Retailer participation in cigarette company incentive programs is related to increased levels of cigarette advertising and cheaper cigarette prices in stores. Feighery EC; Ribisl KM; Schleicher NC; Clark PI Prev Med; 2004 Jun; 38(6):876-84. PubMed ID: 15193911 [TBL] [Abstract][Full Text] [Related]
4. Towards a greater understanding of the illicit tobacco trade in Europe: a review of the PMI funded 'Project Star' report. Gilmore AB; Rowell A; Gallus S; Lugo A; Joossens L; Sims M Tob Control; 2014 May; 23(e1):e51-61. PubMed ID: 24335339 [TBL] [Abstract][Full Text] [Related]
5. How tobacco companies ensure prime placement of their advertising and products in stores: interviews with retailers about tobacco company incentive programmes. Feighery EC; Ribisl KM; Clark PI; Haladjian HH Tob Control; 2003 Jun; 12(2):184-8. PubMed ID: 12773729 [TBL] [Abstract][Full Text] [Related]
6. Tobacco company agreements with tobacco retailers for price discounts and prime placement of products and advertising: a scoping review. Reimold AE; Lee JGL; Ribisl KM Tob Control; 2023 Sep; 32(5):635-644. PubMed ID: 35074932 [TBL] [Abstract][Full Text] [Related]
7. IQOS point-of-sale marketing: a comparison between Arab and Jewish neighborhoods in Israel. Khayat A; Levine H; Berg CJ; Abroms LC; Duan Z; Wang Y; LoParco CR; Elbaz D; Cui Y; Bar-Zeev Y Isr J Health Policy Res; 2024 Aug; 13(1):39. PubMed ID: 39152466 [TBL] [Abstract][Full Text] [Related]
8. Philip Morris International's Formula 1 Sponsorship-Linked Marketing: Transformation From Marlboro to Mission Winnow. Dewhirst T; Lee WB; Czaplicki L Nicotine Tob Res; 2023 Nov; 25(12):1838-1846. PubMed ID: 37702346 [TBL] [Abstract][Full Text] [Related]
9. ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia. Tong EK; Glantz SA Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii118-24. PubMed ID: 15564214 [TBL] [Abstract][Full Text] [Related]
10. Potential Implications for Tobacco Industry Transformation of the Acquisition of Swedish Match by Philip Morris International. Levy DT; Warner KE; Liber AC; Travis N; Sweanor DT; Meza R; Cummings KM Nicotine Tob Res; 2023 Nov; 25(12):1899-1903. PubMed ID: 37535864 [TBL] [Abstract][Full Text] [Related]
11. Successful countering of tobacco industry efforts to overturn Thailand's ENDS ban. Patanavanich R; Glantz S Tob Control; 2021 Nov; 30(e1):e10-e19. PubMed ID: 33229463 [TBL] [Abstract][Full Text] [Related]
12. 'The last line of marketing': Covert tobacco marketing tactics as revealed by former tobacco industry employees. Watts C; Burton S; Freeman B Glob Public Health; 2021 Jul; 16(7):1000-1013. PubMed ID: 32946326 [TBL] [Abstract][Full Text] [Related]
13. IQOS: examination of Philip Morris International's claim of reduced exposure. St Helen G; Jacob Iii P; Nardone N; Benowitz NL Tob Control; 2018 Nov; 27(Suppl 1):s30-s36. PubMed ID: 30158205 [TBL] [Abstract][Full Text] [Related]
14. Industry marketing of tobacco products on social media: case study of Philip Morris International's IQOS. Abroms LC; Wysota CN; Tosakoon S; Khayat A; Duan Z; Bar-Zeev Y; Berg CJ; Levine H Tob Control; 2024 Jun; 33(4):518-524. PubMed ID: 36927516 [TBL] [Abstract][Full Text] [Related]
15. IQOS point-of-sale marketing strategies in Israel: a pilot study. Bar-Zeev Y; Levine H; Rubinstein G; Khateb I; Berg CJ Isr J Health Policy Res; 2019 Jan; 8(1):11. PubMed ID: 30642383 [TBL] [Abstract][Full Text] [Related]
16. The Response of Retailers in Scotland to the Standardised Packaging of Tobacco Products Regulations and Tobacco Products Directive. Purves RI; Moodie C; Eadie D; Stead M Nicotine Tob Res; 2019 Feb; 21(3):309-313. PubMed ID: 30202853 [TBL] [Abstract][Full Text] [Related]
17. 'Preparing ourselves to become an international organization': Thailand Tobacco Monopoly's regional and global strategies. MacKenzie R; Ross H; Lee K Glob Public Health; 2017 Mar; 12(3):351-366. PubMed ID: 28139965 [TBL] [Abstract][Full Text] [Related]
18. Success counteracting tobacco company interference in Thailand: an example of FCTC implementation for low- and middle-income countries. Charoenca N; Mock J; Kungskulniti N; Preechawong S; Kojetin N; Hamann SL Int J Environ Res Public Health; 2012 Apr; 9(4):1111-34. PubMed ID: 22690186 [TBL] [Abstract][Full Text] [Related]
19. Creating demand for foreign brands in a 'home run' market: tobacco company tactics in South Korea following market liberalisation. Lee S; Lee K; Holden C Tob Control; 2014 May; 23(3):e8. PubMed ID: 23152099 [TBL] [Abstract][Full Text] [Related]